Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 2174682, 12 pages
http://dx.doi.org/10.1155/2016/2174682
Research Article

Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury

1Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

Received 9 December 2015; Revised 14 March 2016; Accepted 26 April 2016

Academic Editor: Dezheng Zhao

Copyright © 2016 Hong Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Meran and R. Steadman, “Fibroblasts and myofibroblasts in renal fibrosis,” International Journal of Experimental Pathology, vol. 92, no. 3, pp. 158–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Vilayur and D. C. Harris, “Emerging therapies for chronic kidney disease: what is their role?” Nature Reviews Nephrology, vol. 5, no. 7, pp. 375–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Liu, “Cellular and molecular mechanisms of renal fibrosis,” Nature Reviews Nephrology, vol. 7, no. 12, pp. 684–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Sean Eardley and P. Cockwell, “Macrophages and progressive tubulointerstitial disease,” Kidney International, vol. 68, no. 2, pp. 437–455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Wahl, N. McCartney-Francis, J. B. Allen, E. B. Dougherty, and S. F. Dougherty, “Macrophage production of TGF-β and regulation by TGF-β,” Annals of the New York Academy of Sciences, vol. 593, pp. 188–196, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Bonner, A. R. Osornio-Vargas, A. Badgett, and A. R. Brody, “Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 5, no. 6, pp. 539–547, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Okamoto, S. Takahashi, E. Nakamura, K. Nagaya, T. Hayashi, and K. Fujieda, “Transforming growth factor-β1 induces matrix metalloproteinase-9 expression in human meningeal cells via ERK and Smad pathways,” Biochemical and Biophysical Research Communications, vol. 383, no. 4, pp. 475–479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zhong, M. M. Gencay, L. Bubendorf et al., “ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells,” Journal of Cellular Physiology, vol. 207, no. 2, pp. 540–552, 2006. View at Google Scholar
  9. T. A. Wynn and L. Barron, “Macrophages: master regulators of inflammation and fibrosis,” Seminars in Liver Disease, vol. 30, no. 3, pp. 245–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. G. Nair, K. G. Miller, S. R. Lourenssen, and M. G. Blennerhassett, “Inflammatory cytokines promote growth of intestinal smooth muscle cells by induced expression of PDGF-Rβ,” Journal of Cellular and Molecular Medicine, vol. 18, no. 3, pp. 444–454, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Zernecke, J. Bernhagen, and C. Weber, “Macrophage migration inhibitory factor in cardiovascular disease,” Circulation, vol. 117, no. 12, pp. 1594–1602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Bargagli, C. Olivieri, N. Nikiforakis et al., “Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis,” Respiratory Physiology & Neurobiology, vol. 167, no. 3, pp. 261–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Bruchfeld, J. J. Carrero, A. R. Qureshi et al., “Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation,” Molecular Medicine, vol. 15, no. 3-4, pp. 70–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Hori, S. Sato, J. Yamate et al., “Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide,” European Journal of Histochemistry, vol. 47, no. 4, pp. 317–324, 2003. View at Google Scholar · View at Scopus
  15. D. Heinrichs, M. Knauel, C. Offermanns et al., “Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 42, pp. 17444–17449, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Bai, H. Lu, G. Zhang et al., “Sedum sarmentosum Bunge extract exerts renal anti-fibrotic effects in vivo and in vitro,” Life Sciences, vol. 105, no. 1-2, pp. 22–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-L. Lin, R.-H. Chen, Y.-M. Chen et al., “Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor,” Journal of the American Society of Nephrology, vol. 16, no. 9, pp. 2702–2713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. L. Chevalier, M. S. Forbes, and B. A. Thornhill, “Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy,” Kidney International, vol. 75, no. 11, pp. 1145–1152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Zeisberg and E. G. Neilson, “Mechanisms of tubulointerstitial fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 11, pp. 1819–1834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Xia, M. L. Entman, and Y. Wang, “CCR2 regulates the uptake of bone marrow-derived fibroblasts in renal fibrosis,” PLoS ONE, vol. 8, no. 10, Article ID e77493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Correa-Costa, T. T. Braga, R. J. F. Felizardo et al., “Macrophage trafficking as key mediator of adenine-induced kidney injury,” Mediators of Inflammation, vol. 2014, Article ID 291024, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Y. Hoi, M. J. Hickey, P. Hall et al., “Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice,” Journal of Immunology, vol. 177, no. 8, pp. 5687–5696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Y. Lan, W. Mu, N. Yang et al., “De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis,” The American Journal of Pathology, vol. 149, no. 4, pp. 1119–1127, 1996. View at Google Scholar · View at Scopus
  24. H. Y. Lan, N. Yang, D. J. Nikolic-Paterson et al., “Expression of macrophage migration inhibitory factor in human glomerulonephritis,” Kidney International, vol. 57, no. 2, pp. 499–509, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Sasaki, J. Nishihira, T. Ishibashi et al., “Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney,” Kidney International, vol. 65, no. 2, pp. 469–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill, “M-1/M-2 macrophages and the Th1/Th2 paradigm,” Journal of Immunology, vol. 164, no. 12, pp. 6166–6173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wang and D. C. H. Harris, “Macrophages in renal disease,” Journal of the American Society of Nephrology, vol. 22, no. 1, pp. 21–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. E. K. Rice, G. H. Tesch, Z. Cao et al., “Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II,” Kidney International, vol. 63, no. 4, pp. 1265–1275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Chen, G. Yang, X. Zhang et al., “Induction of MIF expression by oxidized LDL via activation of NF-κB in vascular smooth muscle cells,” Atherosclerosis, vol. 207, no. 2, pp. 428–433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Nishihira, Y. Koyama, and Y. Mizue, “Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide,” Cytokine, vol. 10, no. 3, pp. 199–205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. V. R. Kelley and G. G. Singer, “The antigen presentation function of renal tubular epithelial cells,” Experimental Nephrology, vol. 1, no. 2, pp. 102–111, 1993. View at Google Scholar · View at Scopus
  32. T. Kuroiwa, R. Schlimgen, G. G. Illei, I. B. McInnes, and D. T. Boumpas, “Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides,” The Journal of Immunology, vol. 164, no. 6, pp. 3323–3329, 2000. View at Publisher · View at Google Scholar · View at Scopus